Avian Influenza A (H5N1) Infection in Humans
Top Cited Papers
Open Access
- 29 September 2005
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 353 (13) , 1374-1385
- https://doi.org/10.1056/nejmra052211
Abstract
An unprecedented epizootic avian influenza A (H5N1) virus that is highly pathogenic has crossed the species barrier in Asia to cause many human fatalities and poses an increasing pandemic threat. This summary describes the features of human infection with influenza A (H5N1) and reviews recommendations for prevention and clinical management presented in part at the recent World Health Organization (WHO) Meeting on Case Management and Research on Human Influenza A/H5, which was held in Hanoi, May 10 through 12, 2005.1 Because many critical questions remain, modifications of these recommendations are likely.Keywords
This publication has 64 references indexed in Scilit:
- Influenza A H5N1 Replication Sites in HumansEmerging Infectious Diseases, 2005
- Probable Tiger-to-Tiger Transmission of Avian Influenza H5N1Emerging Infectious Diseases, 2005
- Cross‐Reactivity to Highly Pathogenic Avian Influenza H5N1 Viruses after Vaccination with Nonadjuvanted and MF59‐Adjuvanted Influenza A/Duck/Singapore/97 (H5N3) Vaccine: A Potential Priming StrategyThe Journal of Infectious Diseases, 2005
- Human Disease from Influenza A (H5N1), Thailand, 2004Emerging Infectious Diseases, 2005
- Lack of H5N1 Avian Influenza Transmission to Hospital Employees, Hanoi, 2004Emerging Infectious Diseases, 2005
- Avian Influenza A (H5N1) in 10 Patients in VietnamNew England Journal of Medicine, 2004
- Avian Influenza in Hong Kong 1997–2002Avian Diseases, 2003
- Evaluation of Neuraminidase Enzyme Assays Using Different Substrates To Measure Susceptibility of Influenza Virus Clinical Isolates to Neuraminidase Inhibitors: Report of the Neuraminidase Inhibitor Susceptibility NetworkJournal of Clinical Microbiology, 2003
- Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenzaThe Lancet, 2001
- Efficacy of Zanamivir against Avian Influenza A Viruses That Possess Genes Encoding H5N1 Internal Proteins and Are Pathogenic in MammalsAntimicrobial Agents and Chemotherapy, 2001